Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, is proud to announce the latest addition to its ChemPass AItech-engine – a breakthrough technology for target-protein discovery. The integration of TargetSelector, a new application that streamlines target-protein discovery for active molecule identification, assists researchers in finding suitable target proteins for new products while reducing development time, resources and most importantly, increasing the probability of success.
Proteins play a fundamental role in a wide array of biological processes and serve as the primary targets for developing innovative therapeutics, ag-chemical, ag-biological, and other life science solutions. The precise identification of these protein targets is pivotal in advancing research and discovery across various domains, including pharmaceuticals, agriculture, and environmental applications.
The challenge of finding a target-protein that is novel, safe, and druggable from the thousands of proteins in a relevant organism is enormous. Leveraging predictive machine learning algorithms and genomic data, users gain valuable insights into product requirements such as homology, druggability, essentiality, and biological pathways, efficiently narrowing down the list of potential target-protein, thus optimizing the discovery process.
“ChemPass AI tech-engine is a cutting-edge platform for the identification of small molecules. The addition of the TargetSelector application now enables a broader scope of finding the optimal target-protein for these molecules,” said Dr. Nir Arbel, CPO at Evogene. “Our subsidiary AgPlenus, which focuses on developing ag chemicals, will be the first to benefit from this new improvement, applying it to identify novel mechanisms of action for pesticides. I believe that this significant advancement in Evogene’s ChemPass AI tech-engine, positions us to forge strategic partnerships with industry leaders, unlocking innovation, expediting product development, and delivering groundbreaking solutions that tackle pressing global challenges.”
SOURCE: PRNewswire
